No Yes Ok

Archive

« Older Entries Newer Entries »

LSP Portfolio company Harvest Automation featured on Bloomberg TV Thursday, June 13th, 2013
Harvest Automation, a portfolio company of the LSP Bioventures fund, is featured in an episode of Brink on Bloomberg TV. The robots of Harvest Automation are used for a range of agricultural applications. Harvest enables [...]
Pronota is to receive patent on biomarker for diagnosing renal failure in the US despite Prometheus Thursday, June 6th, 2013
GHENT, BELGIUM, June 6, 2013 – The United States Patent and Trade Office (USPTO) has allowed Pronota’s patent for the use of a blood-based biomarker LG3 in the decision-making process for the treatment of renal dy [...]
GSK strengthens vaccines business with acquisition of Okairos Wednesday, May 29th, 2013
Issued: Wednesday 29 May 2013, London UK GSK strengthens vaccines business with acquisition of Okairos GSK to further expand its vaccines platform technology expertise through strategic acquisition …………… [...]
Celladon Corporation Selected as Winner of Red Herring's "Top 100 North America Tech Startup" Wednesday, May 29th, 2013
SAN DIEGO, May 29, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it had been selected [...]
Biotech Update 2013 Monday, May 27th, 2013
Biotech Update 2013 Friday 28th June 2013 Kasteel De Wittenburg in Wassenaar, The Netherlands [...]
SUPPRESTEM Consortium Led by Merus Receives €6 Million FP7 Grant from the European Union Monday, May 27th, 2013
- Development of Therapeutic Bispecific Antibodies (Biclonics™) Targeting Treatment-resistant Cancer Stem Cells Using Patient-Derived Organoid Screening Tools - Utrecht, The Netherlands, May 27, 2013 – Merus B.V., [...]
Celladon and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference" Wednesday, May 8th, 2013
-Analysis of Recurrent Heart Failure Hospitalizations in Presence of Informative Censoring – Application of Joint Frailty Model- SAN DIEGO, May 8, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical compa [...]
Celladon Corporation is a Finalist for the 2013 Red Herring Top 100 North America Award Tuesday, May 7th, 2013
San Diego, California, May 7, 2013/PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it had bee [...]
TB, HIV and Malaria Vaccine Research Gets Major Boost $2.9 million Grant to Advance Chimpanzee Adenovirus Platform Tuesday, May 7th, 2013
Rockville, MD, US, Oxford, UK and Basel, Switzerland – 7 May 2013 – Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T- [...]
Celladon's gene therapy for heart failure takes spotlight in the U.K. Tuesday, April 30th, 2013
By John Carroll, FierceBiotech San Diego-based Celladon has made a big splash in the U.K. British scientists are playing a prominent role in a pair of clinical trials of Celladon's Mydicar, a gene therapy for heart fa [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
Follow us

No Yes Ok

Archive

« Older Entries Newer Entries »

LSP Portfolio company Harvest Automation featured on Bloomberg TV Thursday, June 13th, 2013
Harvest Automation, a portfolio company of the LSP Bioventures fund, is featured in an episode of Brink on Bloomberg TV. The robots of Harvest Automation are used for a range of agricultural applications. Harvest enables [...]
Pronota is to receive patent on biomarker for diagnosing renal failure in the US despite Prometheus Thursday, June 6th, 2013
GHENT, BELGIUM, June 6, 2013 – The United States Patent and Trade Office (USPTO) has allowed Pronota’s patent for the use of a blood-based biomarker LG3 in the decision-making process for the treatment of renal dy [...]
GSK strengthens vaccines business with acquisition of Okairos Wednesday, May 29th, 2013
Issued: Wednesday 29 May 2013, London UK GSK strengthens vaccines business with acquisition of Okairos GSK to further expand its vaccines platform technology expertise through strategic acquisition …………… [...]
Celladon Corporation Selected as Winner of Red Herring's "Top 100 North America Tech Startup" Wednesday, May 29th, 2013
SAN DIEGO, May 29, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it had been selected [...]
Biotech Update 2013 Monday, May 27th, 2013
Biotech Update 2013 Friday 28th June 2013 Kasteel De Wittenburg in Wassenaar, The Netherlands [...]
SUPPRESTEM Consortium Led by Merus Receives €6 Million FP7 Grant from the European Union Monday, May 27th, 2013
- Development of Therapeutic Bispecific Antibodies (Biclonics™) Targeting Treatment-resistant Cancer Stem Cells Using Patient-Derived Organoid Screening Tools - Utrecht, The Netherlands, May 27, 2013 – Merus B.V., [...]
Celladon and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference" Wednesday, May 8th, 2013
-Analysis of Recurrent Heart Failure Hospitalizations in Presence of Informative Censoring – Application of Joint Frailty Model- SAN DIEGO, May 8, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical compa [...]
Celladon Corporation is a Finalist for the 2013 Red Herring Top 100 North America Award Tuesday, May 7th, 2013
San Diego, California, May 7, 2013/PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it had bee [...]
TB, HIV and Malaria Vaccine Research Gets Major Boost $2.9 million Grant to Advance Chimpanzee Adenovirus Platform Tuesday, May 7th, 2013
Rockville, MD, US, Oxford, UK and Basel, Switzerland – 7 May 2013 – Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T- [...]
Celladon's gene therapy for heart failure takes spotlight in the U.K. Tuesday, April 30th, 2013
By John Carroll, FierceBiotech San Diego-based Celladon has made a big splash in the U.K. British scientists are playing a prominent role in a pair of clinical trials of Celladon's Mydicar, a gene therapy for heart fa [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
X

MONTHLY REPORTS

Here you can subscribe for the monthly report of the LSP Life Sciences Fund